169 related items for PubMed ID: 15641629
1. Efficacy and safety of fluticasone propionate/salmeterol HFA 134A MDI in patients with mild-to-moderate persistent asthma.
Pearlman DS, Peden D, Condemi JJ, Weinstein S, White M, Baitinger L, Scott C, Ho SY, House K, Dorinsky P.
J Asthma; 2004; 41(8):797-806. PubMed ID: 15641629
[Abstract] [Full Text] [Related]
2. Efficacy and tolerability of fluticasone propionate/salmeterol administered twice daily via hydrofluoroalkane 134a metered-dose inhaler in adolescent and adult patients with persistent asthma: a randomized, double-blind, placebo-controlled, 12-week study.
Nathan RA, Rooklin A, Schoaf L, Scott C, Ellsworth A, House K, Dorinsky P.
Clin Ther; 2006 Jan; 28(1):73-85. PubMed ID: 16490581
[Abstract] [Full Text] [Related]
3. Efficacy and safety of fluticasone propionate 44 microg/salmeterol 21 microg administered in a hydrofluoroalkane metered-dose inhaler as an initial asthma maintenance treatment.
Nelson HS, Wolfe JD, Gross G, Greos LS, Baitinger L, Scott C, Dorinsky P.
Ann Allergy Asthma Immunol; 2003 Sep; 91(3):263-9. PubMed ID: 14533658
[Abstract] [Full Text] [Related]
4. Step-down therapy with low-dose fluticasone-salmeterol combination or medium-dose hydrofluoroalkane 134a-beclomethasone alone.
Fowler SJ, Currie GP, Lipworth BJ.
J Allergy Clin Immunol; 2002 Jun; 109(6):929-35. PubMed ID: 12063520
[Abstract] [Full Text] [Related]
5. Fluticasone propionate and salmeterol administered via Diskus compared with salmeterol or fluticasone propionate alone in patients suboptimally controlled with short-acting beta2-agonists.
Murray J, Rosenthal R, Somerville L, Blake K, House K, Baitinger L, VanderMeer A, Dorinsky P.
Ann Allergy Asthma Immunol; 2004 Oct; 93(4):351-9. PubMed ID: 15521371
[Abstract] [Full Text] [Related]
6. Clinical equivalence of salmeterol/fluticasone propionate in combination (50/100 microg twice daily) when administered via a chlorofluorocarbon-free metered dose inhaler or dry powder inhaler to patients with mild-to-moderate asthma.
Bateman ED, Silins V, Bogolubov M.
Respir Med; 2001 Feb; 95(2):136-46. PubMed ID: 11217910
[Abstract] [Full Text] [Related]
7. Salmeterol/fluticasone propionate via Diskus once daily versus fluticasone propionate twice daily in patients with mild asthma not previously receiving maintenance corticosteroids.
Chuchalin A, Jacques L, Frith L.
Clin Drug Investig; 2008 Feb; 28(3):169-81. PubMed ID: 18266402
[Abstract] [Full Text] [Related]
8. Clinical efficacy and safety of fluticasone propionate 250 microg twice daily administered via a HFA 134a pressurized metered dose inhaler to patients with mild to moderate asthma. French study group.
Tonnel AB, Bons J, Legendre M, Prud'Homme A, Bugnas B, Evano-Celli I, Stuart AM.
Respir Med; 2000 Jun; 94 Suppl B():S29-34. PubMed ID: 10919683
[Abstract] [Full Text] [Related]
9. Salmeterol HFA is as effective as salmeterol CFC in children and adults with persistent asthma.
Chopra N, Williams M, Rimmer M, Kahl L, Jenkins M, SMO30006 and SMO30007 International Study Teams.
Respir Med; 2005 Apr; 99 Suppl A():S1-S10. PubMed ID: 15777603
[Abstract] [Full Text] [Related]
10. Tolerability of a salmeterol xinafoate/fluticasone propionate hydrofluoroalkane metered-dose inhaler in adolescent and adult patients with persistent asthma: a 52-week, open-label, stratified, parallel-group, multicenter study.
Cowie RL, Boulet LP, Keith PK, Scott-Wilson CA, House KW, Dorinsky PM.
Clin Ther; 2007 Jul; 29(7):1390-402. PubMed ID: 17825690
[Abstract] [Full Text] [Related]
11. Efficacy and safety of salmeterol/fluticasone propionate delivered via a hydrofluoroalkane metered dose inhaler in Chinese patients with moderate asthma poorly controlled with inhaled corticosteroids.
You-Ning L, Humphries M, Du X, Wang L, Jiang J.
Int J Clin Pract; 2005 Jul; 59(7):754-9. PubMed ID: 15963199
[Abstract] [Full Text] [Related]
12. Combined salmeterol/fluticasone propionate versus fluticasone propionate alone in mild asthma : a placebo-controlled comparison.
Boonsawat W, Goryachkina L, Jacques L, Frith L.
Clin Drug Investig; 2008 Jul; 28(2):101-11. PubMed ID: 18211118
[Abstract] [Full Text] [Related]
13. Effects of fluticasone propionate and salmeterol hydrofluoroalkane inhalation aerosol on asthma-related quality of life.
Edin HM, Andersen LB, Schoaf L, Scott-Wilson CA, Ho SY, Ortega HG.
Ann Allergy Asthma Immunol; 2009 Apr; 102(4):323-7. PubMed ID: 19441604
[Abstract] [Full Text] [Related]
14. The CONCEPT trial: a 1-year, multicenter, randomized,double-blind, double-dummy comparison of a stable dosing regimen of salmeterol/fluticasone propionate with an adjustable maintenance dosing regimen of formoterol/budesonide in adults with persistent asthma.
FitzGerald JM, Boulet LP, Follows RM.
Clin Ther; 2005 Apr; 27(4):393-406. PubMed ID: 15922813
[Abstract] [Full Text] [Related]
15. Clinical efficacy and safety of fluticasone propionate 1 mg twice daily administered via a HFA 134a pressurized metered dose inhaler to patients with severe asthma. U.K. study group.
Ayres JG, Millar AB, Sykes AP.
Respir Med; 2000 Jun; 94 Suppl B():S42-50. PubMed ID: 10919685
[Abstract] [Full Text] [Related]
16. The efficacy and safety of fluticasone propionate (250 microg)/salmeterol (50 microg) combined in the Diskus inhaler for the treatment of COPD.
Hanania NA, Darken P, Horstman D, Reisner C, Lee B, Davis S, Shah T.
Chest; 2003 Sep; 124(3):834-43. PubMed ID: 12970006
[Abstract] [Full Text] [Related]
17. The addition of salmeterol to fluticasone propionate versus increasing the dose of fluticasone propionate in patients with persistent asthma. Salmeterol Study Group.
Condemi JJ, Goldstein S, Kalberg C, Yancey S, Emmett A, Rickard K.
Ann Allergy Asthma Immunol; 1999 Apr; 82(4):383-9. PubMed ID: 10227337
[Abstract] [Full Text] [Related]
18. A comparison of the efficacy and tolerability of single doses of HFA 134a albuterol and CFC albuterol in mild-to-moderate asthmatic patients.
Langley SJ, Sykes AP, Batty EP, Masterson CM, Woodcock A.
Ann Allergy Asthma Immunol; 2002 May; 88(5):488-93. PubMed ID: 12027070
[Abstract] [Full Text] [Related]
19. Salmeterol/fluticasone propionate (50/500 microg) in combination in a Diskus inhaler (Seretide) is effective and safe in the treatment of steroid-dependent asthma.
Aubier M, Pieters WR, Schlösser NJ, Steinmetz KO.
Respir Med; 1999 Dec; 93(12):876-84. PubMed ID: 10653049
[Abstract] [Full Text] [Related]
20. Efficacy and tolerability of salmeterol/fluticasone propionate versus fluticasone propionate in asthma patients: a randomized, double-blind study.
Lee YS, Lin HC, Huang CD, Lee KY, Liu CY, Yu CT, Wang CH, Kuo HP.
Chang Gung Med J; 2011 Dec; 34(4):382-94. PubMed ID: 21880193
[Abstract] [Full Text] [Related]
Page: [Next] [New Search]
